Corbus Pharmaceuticals Holdings, Inc. Loans Payable
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Loans Payable of $0 as of 2024-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Balance Sheet › Liabilities
us-gaap:LoansPayable · last filed 2025-03-11
- 2024-12-31: Loans Payable $0.00.
- 2024-09-30: Loans Payable $0.00.
- 2024-06-30: Loans Payable $10.74M.
- 2023-12-31: Loans Payable $15.91M.
| Period end | Loans Payable |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-11 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-07 |
| 2024-06-30 | $10.74M 10-Q · filed 2024-08-06 |
| 2023-12-31 | $15.91M 10-K · filed 2025-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |